# Sutro Biopharma, Inc.: Form 8-K, filed Nov 8, 2019

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2019-11-08
- Accepted by EDGAR: Nov 8, 2019, 08:00 ET
- Period: 2019-11-07
- Accession: 0001564590-19-042019
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000156459019042019/stro-8k_20191107.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000156459019042019/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000156459019042019/stro-8k_20191107.htm

Filed Nov 8, 2019.
Source: SEC EDGAR, the filing index for accession 0001564590-19-042019. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.